The pain management platform developer has now raised at least $125m altogether, after pulling in series C funding from investors including Optum.

Rakuten took part in a $37m round for virtual kitchen operator Taster while Nano Dimension is buying M12-backed 3D microprinter developer NanoFabrica for up to $54.9m.

Intel, Optum, Relyens and Rezayat Group all invested in the surgery software provider, which is also backed by Mitsubishi, Barco Healthcare, Norgine and Takeda.

Funding from the Anthem-backed series E round will support the commercialisation of Sera's biomarker tests, which predict the chances of preterm births.

The cancer therapy developer has now collected more than $240m altogether, having completed a series C round that included Roche Venture Fund.

Alexandria Venture Investments returned for a series B round that increased the precision oncology drug developer's overall funding to over $150m.

Chief executive Antonin de Fougerolles talks about Evox’s journey to commercialising a new modality that could prove truly transformational.

The University of Bristol spinout is working on adapting cell therapies to solid tumours.

Fungal infection treatment developer Amplyx Pharmaceuticals had disclosed $142m in funding from investors including Pfizer and Lundbeckfonden Ventures.

Applied Ventures helped assay provider Ultivue close a $50m round while clean energy producer Sunseap has followed a $72m series D4 round with more corporate funding.